RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Enzymatica AB (publ) Stock

Enzymatica AB (publ) Net Income 2024

Enzymatica AB (publ) Net Income

-79.23 M SEK

Ticker

ENZY.ST

ISIN

SE0003943620

WKN

A1WZEV

In 2024, Enzymatica AB (publ)'s profit amounted to -79.23 M SEK, a 59.32% increase from the -49.73 M SEK profit recorded in the previous year.

The Enzymatica AB (publ) Net Income history

YEARNET INCOME (undefined SEK)
2026e-
2025e-
2024e-
2023-
2022-
2021-
2020-
2019-
2018-
2017-
2016-
2015-
2014-
2013-
2012-
2011-
2010-
2009-
2008-
2007-

Enzymatica AB (publ) Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Enzymatica AB (publ), a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Enzymatica AB (publ) from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Enzymatica AB (publ)’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Enzymatica AB (publ). Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Enzymatica AB (publ)’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Enzymatica AB (publ)’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Enzymatica AB (publ)’s growth potential.

Enzymatica AB (publ) Revenue, EBIT and net profit per share

DateEnzymatica AB (publ) RevenueEnzymatica AB (publ) EBITEnzymatica AB (publ) Net Income
2026e197.88 M undefined-1.53 M undefined-69.33 M undefined
2025e118.32 M undefined-30.6 M undefined-71.8 M undefined
2024e58.65 M undefined-55.59 M undefined-79.23 M undefined
202350.9 M undefined-48.06 M undefined-49.73 M undefined
202248.95 M undefined-68.22 M undefined-68.66 M undefined
202157.24 M undefined-45.25 M undefined-45.39 M undefined
2020111.25 M undefined-12.06 M undefined-13.22 M undefined
201961.31 M undefined-41.66 M undefined-40.98 M undefined
201852.56 M undefined-40.58 M undefined-42.58 M undefined
201759.45 M undefined-30.21 M undefined-31.45 M undefined
201636.48 M undefined-46.18 M undefined-45.01 M undefined
201527.91 M undefined-40.52 M undefined-40.83 M undefined
201419.06 M undefined-32.67 M undefined-32.39 M undefined
201310.49 M undefined-16.21 M undefined-16.21 M undefined
2012900,000 undefined-7.67 M undefined-7.57 M undefined
2011580,000 undefined-4.92 M undefined-4.99 M undefined
2010340,000 undefined-1.42 M undefined-1.55 M undefined
20090 undefined-70,000 undefined-190,000 undefined
20080 undefined-260,000 undefined-780,000 undefined
20070 undefined0 undefined-50,000 undefined

Enzymatica AB (publ) stock margins

The Enzymatica AB (publ) margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Enzymatica AB (publ). The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Enzymatica AB (publ).

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Enzymatica AB (publ)'s sales revenue. A higher gross margin percentage indicates that the Enzymatica AB (publ) retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Enzymatica AB (publ)'s earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Enzymatica AB (publ)'s total revenue generated. When comparing the revenue margin year over year, investors can gauge the Enzymatica AB (publ)'s growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Enzymatica AB (publ). Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Enzymatica AB (publ)'s financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Enzymatica AB (publ) Margin History

Enzymatica AB (publ) Gross marginEnzymatica AB (publ) Profit marginEnzymatica AB (publ) EBIT marginEnzymatica AB (publ) Profit margin
2026e62.59 %-0.77 %-35.03 %
2025e62.59 %-25.86 %-60.68 %
2024e62.59 %-94.78 %-135.09 %
202362.59 %-94.42 %-97.69 %
202258.13 %-139.37 %-140.27 %
202158.26 %-79.04 %-79.3 %
202068.28 %-10.84 %-11.88 %
201973.23 %-67.95 %-66.84 %
201870.02 %-77.21 %-81.01 %
201761.11 %-50.82 %-52.9 %
201660.93 %-126.57 %-123.36 %
201569.6 %-145.16 %-146.28 %
201474.33 %-171.36 %-169.93 %
2013-70.07 %-154.53 %-154.53 %
2012-342.22 %-852.22 %-841.11 %
2011-450 %-848.28 %-860.34 %
2010-264.71 %-417.65 %-455.88 %
200962.59 %0 %0 %
200862.59 %0 %0 %
200762.59 %0 %0 %

Enzymatica AB (publ) Aktienanalyse

What does Enzymatica AB (publ) do?

Enzymatica AB (publ) is a Swedish healthcare company that specializes in the development, production, and marketing of enzyme technology. It was founded in 2007 and is headquartered in Lund, Sweden. The company is listed on the Nasdaq Stockholm. Enzymatica AB (publ) ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Enzymatica AB (publ)'s Profit Margins

The profit margins of Enzymatica AB (publ) represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Enzymatica AB (publ)'s financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Enzymatica AB (publ)'s profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Enzymatica AB (publ)'s profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Enzymatica AB (publ)’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Enzymatica AB (publ) stock

How much profit has Enzymatica AB (publ) made this year?

Enzymatica AB (publ) has made -79.23 M SEK this year.

How has the profit developed compared to last year?

The profit has increased by 59.32% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Enzymatica AB (publ) publish its earnings?

Enzymatica AB (publ) publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Enzymatica AB (publ)?

The profits of Enzymatica AB (publ) are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Enzymatica AB (publ)?

You can learn more about the earnings of Enzymatica AB (publ) by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Enzymatica AB (publ) pay?

Over the past 12 months, Enzymatica AB (publ) paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Enzymatica AB (publ) is expected to pay a dividend of 0 SEK.

What is the dividend yield of Enzymatica AB (publ)?

The current dividend yield of Enzymatica AB (publ) is .

When does Enzymatica AB (publ) pay dividends?

Enzymatica AB (publ) pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Enzymatica AB (publ)?

Enzymatica AB (publ) paid dividends every year for the past 0 years.

What is the dividend of Enzymatica AB (publ)?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Enzymatica AB (publ) located?

Enzymatica AB (publ) is assigned to the 'Health' sector.

Wann musste ich die Aktien von Enzymatica AB (publ) kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Enzymatica AB (publ) from 9/12/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 9/12/2024.

When did Enzymatica AB (publ) pay the last dividend?

The last dividend was paid out on 9/12/2024.

What was the dividend of Enzymatica AB (publ) in the year 2023?

In the year 2023, Enzymatica AB (publ) distributed 0 SEK as dividends.

In which currency does Enzymatica AB (publ) pay out the dividend?

The dividends of Enzymatica AB (publ) are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Enzymatica AB (publ)

Our stock analysis for Enzymatica AB (publ) Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Enzymatica AB (publ) Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.